| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Apr 20, 2026 | Grant(A) | 11K | — | $0 | 11K |
| Apr 20, 2026 | Grant(A) | 2K | — | $0 | 2K |
| Apr 20, 2026 | Grant(A) | 9K | — | $0 | 9K |
| Apr 20, 2026 | Grant(A) | 195K | — | $0 | 195K |
| Apr 20, 2026 | Grant(A) | 380K | — | $0 | 380K |
| Apr 20, 2026 | Grant(A) | 306K | — | $0 | 306K |
| Apr 20, 2026 | Grant(A) | 133K | — | $0 | 133K |
| Apr 20, 2026 | Grant(A) | 18K | — | $0 | 18K |
| Apr 20, 2026 | Grant(A) | 69K | — | $0 | 69K |
| Apr 20, 2026 | Grant(A) | 81K | — | $0 | 81K |
| Apr 20, 2026 | Grant(A) | 99K | — | $0 | 99K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001673528-26-000010) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for First Tracks Biotherapeutics, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.